Matthew O'Brien
Stock Analyst at Piper Sandler
(0.07)
# 4,298
Out of 4,339 analysts
1239
Total ratings
35.7%
Success rate
-8.2%
Average return
Main Sectors:
Stocks Rated by Matthew O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintained: Buy | $360 → $210 | $153.80 | +36.54% | 36 | May 22, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $120 | $70.46 | +70.31% | 36 | May 22, 2026 | |
| BBNX Beta Bionics | Maintained: Buy | $20 | $11.72 | +70.65% | 10 | May 22, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $90 | $57.64 | +56.14% | 60 | May 19, 2026 | |
| MDT Medtronic | Reiterated: Hold | $91 | $77.60 | +17.27% | 57 | May 19, 2026 | |
| SI Shoulder Innovations | Maintained: Buy | $19 | $15.06 | +26.16% | 4 | May 14, 2026 | |
| TELA TELA Bio | Reiterated: Hold | $1 | $0.814 | +22.85% | 26 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Maintained: Buy | $15 → $9 | $3.97 | +126.70% | 9 | May 13, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $12 | $6.08 | +97.37% | 23 | May 12, 2026 | |
| KMTS Kestra Medical Technologies | Maintained: Buy | $30 | $21.82 | +37.49% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $85.10 | +35.14% | 53 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $14.54 | +126.96% | 34 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $14 | $8.06 | +73.70% | 37 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $28.86 | +73.28% | 41 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $11.89 | +51.39% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $72.01 | +4.15% | 65 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $97 | $90.14 | +7.61% | 14 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $420 | $313.00 | +34.19% | 53 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $17.90 | +22.91% | 29 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 | $36.06 | +8.15% | 41 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $35 | $27.45 | +27.50% | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.75 | +300.00% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $11.18 | +43.11% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $14.67 | +70.42% | 6 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $28.40 | +33.80% | 3 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $328.20 | +13.95% | 18 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $84.41 | - | 42 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $4.99 | n/a | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $33.34 | n/a | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $245 → $140 | $131.89 | n/a | 26 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $11 | $4.25 | n/a | 20 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $180 | $114.97 | n/a | 62 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4.5 → $2 | $4.09 | n/a | 26 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $3 | $1.11 | n/a | 7 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $44 | $15.19 | n/a | 38 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $90 | $0.0001 | n/a | 15 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $1.14 | n/a | 7 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $1.22 | n/a | 24 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 | $19.38 | n/a | 16 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $79 | $64.52 | n/a | 25 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $25.06 | n/a | 14 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $4.20 | n/a | 6 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $435 | $62.03 | n/a | 30 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $0.89 | n/a | 10 | Jan 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $7 | $0.000001 | n/a | 8 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $73 | $75.42 | n/a | 38 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $258 → $345 | $163.55 | n/a | 35 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 → $633 | $436.64 | n/a | 27 | Sep 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $3 | $6.98 | n/a | 3 | Jan 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.67 | n/a | 9 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $96 | $6.58 | n/a | 8 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $69 | $9.99 | n/a | 9 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $70 | $207.98 | n/a | 8 | Aug 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.4612 | n/a | 2 | Aug 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.62 | n/a | 2 | May 8, 2012 |
Insulet
May 22, 2026
Maintained: Buy
Price Target: $360 → $210
Current: $153.80
Upside: +36.54%
TransMedics Group
May 22, 2026
Maintained: Buy
Price Target: $120
Current: $70.46
Upside: +70.31%
Beta Bionics
May 22, 2026
Maintained: Buy
Price Target: $20
Current: $11.72
Upside: +70.65%
Boston Scientific
May 19, 2026
Maintained: Buy
Price Target: $90
Current: $57.64
Upside: +56.14%
Medtronic
May 19, 2026
Reiterated: Hold
Price Target: $91
Current: $77.60
Upside: +17.27%
Shoulder Innovations
May 14, 2026
Maintained: Buy
Price Target: $19
Current: $15.06
Upside: +26.16%
TELA Bio
May 13, 2026
Reiterated: Hold
Price Target: $1
Current: $0.814
Upside: +22.85%
Orchestra BioMed Holdings
May 13, 2026
Maintained: Buy
Price Target: $15 → $9
Current: $3.97
Upside: +126.70%
CVRx, Inc.
May 12, 2026
Reiterated: Buy
Price Target: $12
Current: $6.08
Upside: +97.37%
Kestra Medical Technologies
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $21.82
Upside: +37.49%
May 8, 2026
Maintained: Buy
Price Target: $115
Current: $85.10
Upside: +35.14%
May 8, 2026
Maintained: Buy
Price Target: $33
Current: $14.54
Upside: +126.96%
May 6, 2026
Maintained: Buy
Price Target: $25 → $14
Current: $8.06
Upside: +73.70%
May 6, 2026
Reiterated: Buy
Price Target: $50
Current: $28.86
Upside: +73.28%
May 6, 2026
Maintained: Buy
Price Target: $18
Current: $11.89
Upside: +51.39%
May 1, 2026
Maintained: Buy
Price Target: $75
Current: $72.01
Upside: +4.15%
May 1, 2026
Maintained: Buy
Price Target: $82 → $97
Current: $90.14
Upside: +7.61%
May 1, 2026
Maintained: Buy
Price Target: $420
Current: $313.00
Upside: +34.19%
May 1, 2026
Maintained: Buy
Price Target: $22
Current: $17.90
Upside: +22.91%
Apr 30, 2026
Reiterated: Hold
Price Target: $39
Current: $36.06
Upside: +8.15%
Apr 30, 2026
Maintained: Buy
Price Target: $28 → $35
Current: $27.45
Upside: +27.50%
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.75
Upside: +300.00%
Mar 31, 2026
Initiated Coverage: Hold
Price Target: $16
Current: $11.18
Upside: +43.11%
Mar 23, 2026
Reiterated: Buy
Price Target: $25
Current: $14.67
Upside: +70.42%
Mar 19, 2026
Maintained: Buy
Price Target: $38
Current: $28.40
Upside: +33.80%
Jan 15, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $328.20
Upside: +13.95%
Oct 13, 2025
Maintained: Hold
Price Target: n/a
Current: $84.41
Upside: -
May 9, 2025
Maintained: Hold
Price Target: $3.5
Current: $4.99
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $16
Current: $33.34
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $245 → $140
Current: $131.89
Upside: n/a
Feb 14, 2025
Maintained: Hold
Price Target: $12 → $11
Current: $4.25
Upside: n/a
Jan 27, 2025
Maintained: Buy
Price Target: $140 → $180
Current: $114.97
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $4.5 → $2
Current: $4.09
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5 → $3
Current: $1.11
Upside: n/a
Jun 26, 2023
Maintained: Hold
Price Target: $55 → $44
Current: $15.19
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $10 → $90
Current: $0.0001
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $9 → $11
Current: $1.14
Upside: n/a
Nov 9, 2021
Maintained: Buy
Price Target: $12 → $10
Current: $1.22
Upside: n/a
Sep 2, 2021
Maintained: Hold
Price Target: $82
Current: $19.38
Upside: n/a
Jul 30, 2021
Maintained: Buy
Price Target: $62 → $79
Current: $64.52
Upside: n/a
Jul 6, 2021
Maintained: Buy
Price Target: $70
Current: $25.06
Upside: n/a
Mar 23, 2021
Maintained: Hold
Price Target: $3.5
Current: $4.20
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $370 → $435
Current: $62.03
Upside: n/a
Jan 27, 2021
Maintained: Hold
Price Target: $7
Current: $0.89
Upside: n/a
Jan 12, 2021
Maintained: Buy
Price Target: $4 → $7
Current: $0.000001
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $70 → $73
Current: $75.42
Upside: n/a
Jul 23, 2020
Maintained: Buy
Price Target: $258 → $345
Current: $163.55
Upside: n/a
Sep 25, 2019
Maintained: Buy
Price Target: $600 → $633
Current: $436.64
Upside: n/a
Jan 7, 2018
Reiterated: Buy
Price Target: $10 → $3
Current: $6.98
Upside: n/a
Dec 13, 2017
Reiterated: Buy
Price Target: $18
Current: $3.67
Upside: n/a
Nov 7, 2017
Reiterated: Hold
Price Target: $90 → $96
Current: $6.58
Upside: n/a
Aug 9, 2017
Reiterated: Buy
Price Target: $73 → $69
Current: $9.99
Upside: n/a
Aug 2, 2017
Reiterated: Hold
Price Target: $65 → $70
Current: $207.98
Upside: n/a
Aug 14, 2014
Maintained: Buy
Price Target: n/a
Current: $0.4612
Upside: n/a
May 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $8.62
Upside: n/a